Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biovail Pharmaceuticals

1997 FOUNDED
M&A STATUS
91-100 EMPLOYEES
M&A LATEST DEAL TYPE
$162M LATEST DEAL AMOUNT
Description

Manufacturer of pharmaceutical products. The company offers products for the treatment of respiratory and allergy conditions, and skin and soft tissue infections. It engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products.

Formerly Known As
DJ Pharma
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Distributors/Wholesale
Other Industries
Pharmaceuticals
Acquirer
Biovail
Primary Office
  • 700 Route 202/206 North
  • Bridgewater, NJ 08807
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Biovail Pharmaceuticals’s full profile, request a free trial.

Biovail Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 06-Oct-2000 $162M 0000 00000 Completed Product Development
1. Early Stage VC (Series A) 26-Jan-1999 0000 0000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Biovail Pharmaceuticals Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Chicago Growth Partners PE/Buyout Majority 000 0000 000000 0
Dura Pharmaceuticals Corporation Minority 000 0000 000000 0
Elan Corporation 000 0000 000000 0
PPM America Asset Manager 000 0000 000000 0

Biovail Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Doug Squires Chief Executive Officer
David Keefer Senior Vice President, Operations

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »